解读骨髓微环境在多发性骨髓瘤免疫疗法耐药性的作用
Nicolas Thomas Iannozzi1, Nicola Giuliani1,2, Paola Storti1
1Department of Medicine and Surgery, University of Parma, Parma, Italy.
Frontiers in immunology
|August 4, 2025
概括
多发性髓瘤 (MM) 涉及复杂的骨髓 (BM) 微环境. 这种微环境阻碍了免疫疗法反应,并驱动了MM患者的耐药性.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 是一种血细胞恶性瘤.
- 骨髓 (BM) 微环境对于MM的进展至关重要.
- 乳腺癌的发病包括BM内的复杂的细胞和非细胞相互作用.
研究的目的:
- 审查MM患者的BM微环境变化.
- 阐明BM微环境如何促进免疫疗法耐药性.
- 讨论对新型治疗策略的影响.
主要方法:
- 关于MM和BM微环境相互作用的文献综述.
- 分析BM的细胞和非细胞组成部分.
- 检查免疫疗法耐药性机制.
主要成果:
- 肌肉瘤微环境显著影响肌肉瘤的进展和药物反应.
- 脑膜微环境中的乱与对免疫疗法的耐药性有关.
- 特定的细胞和非细胞成分介导对单克隆抗体,CAR-T细胞和双特异性T细胞参与剂的耐药性.
结论:
- 脑膜炎微环境是导致脑膜炎治疗失败的关键因素.
- 准BM微环境可以克服免疫疗法耐药性.
- 了解这些相互作用对于改善MM患者的治疗结果至关重要.
相关概念视频
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
01:22Bone Marrow Sampling and Transplants
500
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
500
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:01Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K